Catalpol has a protective effect on the endothelium in type 2 diabetes mellitus and its mechanism may be associated with the negative regulation of Nox4 and p22phox expression, inhibiting the oxidative stress reaction response [67]. This evidence concerns the gene NOX4 and type 2 diabetes mellitus.